FDS supplementation significantly decreased C-reactive protein levels as a biomarker of inflammation ( @ vs. @ mg/l , p < @ ) and lipid peroxidation in the form of MDA ( @ vs. @ nmol/ml , p < @ ) at @ weeks compared to the baseline .